Institutional members access full text with Ovid®

Share this article on:

A Weight Loss Product Is Linked To Liver Injury

Aschenbrenner, Diane S. MS, APRN-BC

AJN The American Journal of Nursing: August 2009 - Volume 109 - Issue 8 - p 26
doi: 10.1097/01.NAJ.0000358488.38313.c6
Drug Watch
  • The FDA is advising consumers not to use Hydroxycut because of 23 case reports of liver damage thought to be attributable to its use.
  • The manufacturer has agreed to withdraw the product from the market.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD.

She also coordinates Drug Watch:

© 2009 Lippincott Williams & Wilkins, Inc.